• Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 52-Week Low After Analyst Downgrade

    Source: Buzz FX / 10 Jan 2025 13:51:15   America/New_York


    Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 52-Week Low After Analyst Downgrade Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN - Get Free Report ) reached a new 52-w
    Read more...
Share on,